Is Fosaprepitant Dimeglumine Injection in shortage?
Fosaprepitant Dimeglumine Injection is listed by FDA as being discontinued by at least one maker (updated Apr 8, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Fosaprepitant Dimeglumine, Injection, 150 mg/5 mL (NDC 63323-972-10)
Discontinuation of the manufacture of the drug
Maker contact: 888-386-1300
FDA recalls of Fosaprepitant Dimeglumine
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Fosaprepitant Dimeglumine Injection:
Fosaprepitant Dimeglumine Injection shortage questions
Is Fosaprepitant Dimeglumine Injection in shortage?
Fosaprepitant Dimeglumine Injection is listed by FDA as being discontinued by at least one maker (updated Apr 8, 2026).
What should I do if I can’t get Fosaprepitant Dimeglumine Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.